Gennex Laboratories is currently trading at Rs. 7.75, up by 0.19 points or 2.51% from its previous closing of Rs. 7.56 on the BSE.
The scrip opened at Rs. 7.78 and has touched a high and low of Rs. 7.83 and Rs. 7.31 respectively. So far 339397 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 12.90 on 07-Jul-2021 and a 52 week low of Rs. 3.72 on 30-Mar-2021.
Last one week high and low of the scrip stood at Rs. 8.13 and Rs. 7.31 respectively. The current market cap of the company is Rs. 97.79 crore.
The promoters holding in the company stood at 22.05% and Non-Institutions held 77.95%.
Gennex Laboratories is planning to raise funds by issuance of equity shares or any other securities, through permissible modes including but not limited to a rights issue, as may be permitted under applicable law and subject to such regulatory/ statutory approvals, as may be required. A meeting of Board of Directors of the Company will be held on April 06, 2022 to consider the same.
Gennex Laboratories is engaged in the manufacture and export of bulk drugs and intermediates. The product range of the company includes Guaiphenesin,Methocarbamol,Fluconazole and Phenazopyridine.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |